IMPACT OF CLONAL HEMATOPOIESIS AND CANAKINUMAB ON NON-HEMATOLOGICAL MALIGNANCY: ANALYSIS OF THE CANTOS RANDOMIZED CLINICAL TRIAL

EHA Library, Janghee Woo, 385787

MONOCYTE-DRIVEN INFLAMMATION IN DNMT3A-MUTANT CLONAL HAEMATOPOIESIS ACUTE ST-ELEVATION MYOCARDIAL INFARCTION.

EHA Library, Sarah Mackie, 385788

LC3-ASSOCIATED PHAGOCYTOSIS IS IMPAIRED IN BONE MARROW MACROPHAGES DURING AGEING LEADING TO DEFECTIVE PHAGOCYTOSIS AND ACCUMULATION OF APOPTOTIC DEBRIS WITHIN THE BONE MARROW.

EHA Library, Katherine Hampton, 385789

THE IMPACT OF CLONAL HEMATOPOIESIS ON THE RISK OF SEVERE COVID-19 INFECTION

EHA Library, Ryunosuke Saiki, 385790

TNIK SIGNALLING IMPAIRS SELF-RENEWAL AND LONG-TERM RECONSTITUTION CAPACITY OF HSCS

EHA Library, Luca Palombella, 385791

SILK BONE MARROW-LIKE TISSUE MODELS FOR PRODUCING ERYTHROCYTES EX VIVO

EHA Library, Christian Di Buduo, 385792

EFFECT OF DECITABINE ON MACROPHAGE PHENOTYPE AND FUNCTION IN VITRO IN THE CONTEXT OF AML

EHA Library, Jacobien Hilberink, 385793

THE IMPACT OF CYTOTOXIC THERAPY ON THE RISK OF PROGRESSION AND DEATH IN PATIENTS WITH CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE.

EHA Library, Marissa Li, 385794

H3K36 HISTONE METHYLTRANSFERASE NSD3 FUNCTIONS AS A CRUCIAL EPIGENETIC REGULATOR OF ERYTHROPOIESIS

EHA Library, Arunim Shah, 385795

C3G CONTROLS MEGAKARYOCYTE INFLUENCE ON MYELOID COMMITMENT OF HEMATOPOIETIC STEM CELLS UPON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION.

EHA Library, Óscar Herranz, 385796

EXTRACELLULAR ATP CONTRIBUTES TO ERYTHROPOIESIS-SUPPORTIVE MICROENVIRONMENT UNDER CHRONIC STRESS CONDITIONS

EHA Library, Sanja Momčilović, 385797

M2-LIKE MONOCYTE-DERIVED MACROPHAGES PROTECT AML CELL LINES AND PRIMARY AML CELLS AGAINST THERAPY-INDUCED APOPTOSIS

EHA Library, Katerina Miari, 385798

REAFFIRMING HEMATOPOIETIC PROGENITORS LINEAGE COMMITMENT BY TRANSCRIPTIONAL ATLAS

EHA Library, Yongjian Yue, 385799

BONE MARROW MORPHOLOGY DIAGNOSTIC ENVIRONMENT USING YOLO/RESNET ARTIFICIAL INTELLIGENCE MODEL

EHA Library, Matjaz Sever, 385800

EXPLORING A NOVEL TREATMENT STRATEGY FOR ACQUIRED APLASTIC ANEMIA TARGETING PPAR SIGNALING PATHWAY.

EHA Library, Liping Yang, 385801

CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.

EHA Library, Nawid Albinger, 385802

DELIVERY OF THERAPEUTIC RNA TO THE BONE MARROW IN MULTIPLE MYELOMA USING CD38-TARGETED LIPID NANOPARTICLES

EHA Library, Dana Tarab-Ravski, 385803

CD84-TARGETED CART-CELL THERAPY: A NOVEL STRATEGY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES

EHA Library, Nela Klein González, 385804

MILESTONE (MODIFYING ELANE GOLDBERG–HOGNES BOX TO INHIBIT EXPRESSION), A UNIVERSAL, SAFE AND EFFECTIVE CRISPR/CAS9N-MEDIATED GENOME EDITING STRATEGY FOR ELANE RELATED SEVERE CONGENITAL NEUTROPENIA

EHA Library, Masoud Nasri, 385805

MINING THE GENOME FOR ERYTHROID SPECIFIC ENHANCERS TO OPTIMIZE GENE THERAPY VECTORS FOR BETA-HEMOGLOBINOPATHIES

EHA Library, Kiriaki Paschoudi, 385806

TUMOR-SPECIFIC, T-CELL-TARGETING MICRORNA IS ASSOCIATED WITH CART CELL FAILURE IN B CELL MALIGNANCIES

EHA Library, Karan Chohan, 385807

CLINICAL TRANSLATION OF A NOVEL, POTENT AND WELL-CHARACTERIZED INDUCED REGULATORY T-CELL PRODUCT AGAINST GRAFT VERSUS HOST DISEASE

EHA Library, Memnon Lysandrou, 385808

SLEEPING BEAUTY PLATFORM FOR ENGINEERING CAR-CIK CELLS TOWARD A MULTI-TARGETING STRATEGY IN B-ALL

EHA Library, Alex Moretti, 385809

DEVELOPMENT OF A NOVEL ONCOLYTIC VIRUS -THEO-310 - SPECIALISED FOR TARGETING THE BONE MARROW TUMOUR MICROENVIRONMENT OF MULTIPLE MYELOMA PATIENTS

EHA Library, Margaret Duffy, 385810

NOVEL DUAL-TARGETING AND SURFACE-ENGINEERED BIO-ORTHOGONALLY LENTIVIRAL VECTORS FOR IN VIVO CAR-T CELLS GENERATION

EHA Library, Heng Mei, 385811

PHARMACOKINETIC PROFILE OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A), FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T CELL THERAPY FOR PATIENTS WITH RELAPSED / REFRACTORY B CELL MALIGNANCIES (IMAGINE STUDY)

EHA Library, Anil Kamat, 385812

HUMAN CD117 AS AN IMMUNOTHERAPEUTIC TARGET IN PRECLINICAL MODELS OF ADVANCED SYSTEMIC MASTOCYTOSIS

EHA Library, Anne Kaiser, 385813

SAR442257, A CD38/CD28/CD3 TRISPECIFIC ANTIBODY, POTENTIATES CAR T-CELL ACTIVITY AGAINST LARGE B-CELL LYMPHOMA

EHA Library, Patrick Reville, 385814

REFINED PHENOTYPE OF SENESCENT T CELLS UNVEILS HIGH ANTI-TUMOR ACTIVITY DESPITE IMPAIRED PROLIFERATION AND DISTURBED METABOLIC ACTIVITY: NEW IMPLICATIONS FOR CANCER IMMUNOTHERAPY

EHA Library, Kevin Legscha, 385815

NKG2A DELETION IN HUMAN NATURAL KILLER CELLS ENHANCES ANTI-TUMOR RESPONSES AND PROMOTES TUMOR INFILTRATION

EHA Library, Roel Klein Wolterink, 385816

HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY

EHA Library, Hiroko Nishida, 385817

A NOVEL GENE THERAPY VECTOR FOR BETA-HEMOGLOBINOPATHIES WITH A SELECTIVE EXPANSION CASSETTE

EHA Library, ALEXANDRA KIRTSOU, 385818

COMPARISON OF DIFFERENT METHODS FOR GENETIC CORRECTION OF GRISCELLI SYNDROME TYPE II-DERIVED STEM CELLS

EHA Library, Özgür Dogus Erol, 385819

NON-MYELOTOXIC CHEMICALS AS A PREPARATORY REGIMEN FOR HEMATOPOIETIC STEM CELL GENE THERAPY

EHA Library, MEHMET EMİN ŞEKER, 385820

UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS

EHA Library, Martina Fiumara, 385821

RAMAN SPECTROSCOPY STUDIES OF IMMUNE RESPONSE ELEMENTS

EHA Library, Paulina Laskowska, 385822

VENETOCLAX MODULATES TIM-3 EXPRESSION ON CD8 T CELLS IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Darina Ocadlikova, 385823

IDENTIFICATION OF SURFACEOME CHANGES IN CD19 CAR-T THERAPY-RESISTANT LYMPHOMA CELLS

EHA Library, Marta Krawczyk, 385824

TRANSCRIPTOME-WIDE ANALYSIS OF T CELLS DURING EX VIVO EXPANSION AS PER CURRENT CAR T CELL MANUFACTURING PROTOCOL REVEALS SPECIFIC CHANGES IN T CELL SIGNALING AND HOMING

EHA Library, Harish Sudarsanam, 385825

CAR-T CELLS TARGETING CD38 AND LMP1 EXHIBIT ROBUST ANTI-TUMOR ACTIVITY AGAINST NK/T-CELL LYMPHOMA

EHA Library, Manu Juneja, 385826

DEVELOPMENT OF A GENE THERAPY CELL DEATH-INDUCING SYSTEM REGULATED BY MICRORNAS FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Mafalda Duque, 385827

THE COMPOSITION OF INFUSED CD19-CAR-T PRODUCT IMPACTS ON EFFICACY

EHA Library, Eugenio Galli, 385828

DISTINCT CYTOKINE SIGNATURES OF IDECABTAGENE VICLEUCEL COMPARED TO AXICABTAGENE CILEUCEL AND LISOCABTAGENE MARALEUCEL

EHA Library, Abu-Sayeef Mirza, 385829

CIRCULATING CAR-T CELLS MONITORING OF KINETICS AND EXHAUSTION MARKERS AS PREDICTIVE FACTORS IN B-CELL MALIGNANCIES

EHA Library, Belén Sierro Martínez, 385830

STRONG AND SELECTIVE EX VIVO EXPANSION OF ADAPTIVE NKG2C+/CD57+ NK CELLS FROM CMV SEROPOSITIVE DONORS USING DENDRITIC CELLS DERIVED FROM THE LEUKEMIC CELL LINE DCONE AS FEEDER CELLS.

EHA Library, Hester van Zeeburg, 385831

MULTI-EFFECTOR IMMUNE CELL RETARGETING USING A BISPECIFIC SINGLE-CHAIN VARIABLE FRAGMENT LIBRARY IN AGGRESSIVE B CELL LYMPHOMAS

EHA Library, Max Freihammer, 385832

DISTINCT RATES OF ICANS BUT SIMILAR CYTOKINE SIGNATURES BETWEEN TWO CD19-CAR T CELL THERAPIES: LISOCABTAGENE MARALEUCEL AND AXICABTAGENE CILOLEUCEL

EHA Library, Yusuf Rasheed, 385833

USE OF A FOAMY-VIRUS VECTOR SYSTEM TO PRODUCE AN ‘OFF-THE-SHELF’ FCΓ-CR-T CELL PRODUCT FOR THE TREATMENT OF HEMATOLOGICAL AND SOLID TUMOR MALIGNANCIES

EHA Library, Ioanna Lazana, 385834

TREATMENT WITH A LEUKEMIA-DERIVED DENDRITIC CELL VACCINE INDUCES INNATE AND ADAPTIVE IMMUNE RESPONSE CORRELATING WITH  CLINICAL RESPONSE IN AML PATIENTS IN CR1 WITH MEASURABLE RESIDUAL DISEASE

EHA Library, Hester van Zeeburg, 385835

EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE

EHA Library, Sylvain Choquet, 385836

A NOVEL AND SUCCESSFUL CD7-TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY FOR REFRACTORY/RELAPSED MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL)

EHA Library, Peihua Lu, 385837

NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN-LABEL GLOBAL PHASE3 STUDY OF TAB-CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)

EHA Library, Daan Dierickx, 385838

VARNIMCABTAGENE AUTOLEUCEL (VAR-CEL) IN RELAPSED / REFRACTORY CD19+ NON-HODGKIN LYMPHOMA

EHA Library, Nuria Martinez-Cibrian, 385839

INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I-II CLINICAL TRIAL OF EX-VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW-UP

EHA Library, Francesca Tucci, 385840

BISPECIFIC CD19/CD37 CAR-T CELLS IN PATIENTS WITH REFRACTORY OR RELAPSED B-CELL LYMPHOMA

EHA Library, Heng Mei, 385841

RITUXIMAB BASED LYMPHODEPLETION MAY INCREASE ENGRAFTMENT AND EFFICACY OF SECOND INFUSIONS OF CART19 CELLS IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Valentín Ortiz-Maldonado, 385842

PENTAVALENT-SPECIFIC T-CELLS POST HAPLO-IDENTICAL TRANSPLANTATION FOR THE TREATMENT OF OPPORTUNISTIC INFECTIONS

EHA Library, Zoi BOUSIOU, 385843

CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WITHOUT CYTOPENIAS

EHA Library, Guenther Koehne, 385844

THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Koray Yalcin, 385845

AXICABTAGENE CILOLEUCEL VERSUS TISAGENLECLEUCEL CAR-T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Nico Gagelmann, 385846

INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER'S TRANSFORMATION

EHA Library, Julio Delgado, 385847

THREE YEARS OUTCOMES OF PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS FOLLOWING ANTI CD19 CAR-T CELL THERAPY - A SINGLE CENTER EXPERIENCE

EHA Library, Mika Geva, 385848

IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.

EHA Library, Marina Gómez-Llobell, 385849

INFUSION OF 14 DAYS BLINATUNOMAB IN COMBINATION WITH CHEMOTHERAPY FOR 46-DAY MRD+ PEDIATRIC B-ALL PATIENTS IN INTERMEDIATE/HIGH-RISK GROUP RESULTS IN MRD CONVERSION.

EHA Library, Changwen Xue, 385850

SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT

EHA Library, Jaap Jan Boelens, 385851

IL-10 PLUS THE EASIX SCORE PREDICT BLEEDING EVENTS AFTER ANTI-CD19 CAR T-CELL THERAPY

EHA Library, Heng Mei, 385852

IN-DEPTH GENOME INTEGRITY EVALUATION AND GMP-COMPLIANT MANUFACTURING OF HDR GENE EDITED CD4+ T CELLS FOR THE TREATMENT OF HYPER IGM 1

EHA Library, Daniele Canarutto, 385853

SAFETY AND EFFICACY OF IBI346, A FIRST-IN-CLASS BCMA-TARGETING MODULAR CAR-T CELL THERAPY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PRELIMINARY RESULTS FROM TWO PHASE I STUDIES

EHA Library, Zhengzheng Fu, 385854

REMOTE MONITORING OF CAR T-CELL TREATED PATIENTS BY A SPECIALIZED NURSE TO DETECT AND MANAGE LATE COMPLICATIONS: REPORT OF THE CARAMA PROGRAM

EHA Library, Fanny Colin, 385855

UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

EHA Library, Nicolas Boissel, 385856

PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY

EHA Library, Anil Kamat, 385857

EFFICACY OBSERVATION OF A SECOND INFUSION OF BCMA-CAR-T CELLS IN PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA

EHA Library, Yi Wang, 385858

FIRST EVALUATION OF A MOBILE HEALTH APP DEVELOPED TO MONITOR ACUTE TOXICITIES AFTER CAR T-CELL THERAPY: A THINK ALOUD STUDY WITH PATIENT EXPERTS

EHA Library, Milan Kos, 385859

CLINICIAN LED NUTRITIONAL ASSESSMENT AND PRE-OPTIMISATION OF PATIENTS UNDERGOING CAR-T CELL THERAPY

EHA Library, Frances Seymour, 385860

DOES TOCILIZUMAB INCREASE THE RISK OF INFECTIONS IN PATIENTS UNDERGOING CAR-T THERAPY?

EHA Library, Mona Asslan, 385861

CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY

EHA Library, Shota Yokoyama, 385862

CELLULAR DYNAMICS IN RESPONDERS AND NON-RESPONDERS AFTER THE TREATMENT OF PATIENTS WITH AGGRESSIVE B-ZELL LYMPHOMAS WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS

EHA Library, Vladan Vucinic, 385863

THE CLINICAL SPECTRUM AND PROGNOSTIC FACTORS OF ERDHEIM-CHESTER DISEASE

EHA Library, Jia-Wen Dai, 385864

BASELINE CALCIUM WAS ASSOCIATED WITH PROGNOSIS AFTER CAR T-CELL THERAPY

EHA Library, Heng Mei, 385865

DETERMINANTS OF HAEMOGLOBIN IN SICKLE CELL DISEASE PATIENTS IN SUB-SAHARAN AFRICA: MAJOR IMPACT OF THE NATIVE COUNTRY AND INDEPENDENT EFFECTS OF INFLAMMATION AND HAEMOLYSIS.

EHA Library, Marica Rossi, 385866

A SINGLE CENTRE PERSPECTIVE ON PREGNANCY OUTCOMES AND SICKLE CELL COMPLICATIONS IN WOMEN ON HYDROXYCARBAMIDE PERI-CONCEPTION.

EHA Library, Maria Gregori, 385867

COMPARATIVE STUDY OF CYCLOSPORINE VERSUS TACROLIMUS IN ADDITION TO METHOTREXATE AS GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING ALLOGENEIC STEM CELL TRANSPLANTATION OF SICKLE CELL DISEASE

EHA Library, Mostafa Mohammed Saleh, 385868

THE EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON CEREBRAL PERFUSION AND OXYGEN METABOLISM IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Liza Afzali-Hashemi, 385869

PREVALENCE AND RISK FACTORS FOR RETINOPATHY IN SICKLE CELL DISEASE

EHA Library, Kate Gardner, 385870

GENOTYPE GUIDED DISEASE MANAGEMENT IN HBSC SICKLE CELL DISEASE USING PHLEBOTOMY: IMPACT ON SYMPTOMS AND DISEASE PARAMETERS

EHA Library, Anne-Marie Asemissen, 385871

ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE

EHA Library, Myrthe van Dijk, 385872

SYSTEMATIC INVESTIGATION OF HYDROXYUREA TREATMENT EFFECT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Varsha Bhat, 385873

RARE ANAEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP): DISTRIBUTION OF PATIENTS AFFECTED BY RADS IN EUROPE

EHA Library, Maria Del Mar Mañú Pereira, 385875

PREDICTORS OF VOC RATE DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH HBSS IN A NEWBORN COHORT STUDY

EHA Library, Muriel Ramalli, 385876

IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM

EHA Library, Chiara Federici, 385877

EPIDEMIOLOGY AND TREATMENT OF SICKLE CELL DISEASE ASSOCIATED VASO-OCCLUSIVE CRISES IN INPATIENT AND EMERGENCY CARE SETTINGS:  A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

EHA Library, Ami Patel, 385878

ACCURATE CELL-FREE HEME DOSAGE IN PLASMA CORRELATES WITH ANEMIA, HEMOLYSIS AND SICKLE CELL NEPHROPATHY SEVERITY

EHA Library, Laura Bencheikh, 385879

PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Biree Andemariam, 385880

POSITRON EMISSION TOMOGRAPHY IMAGING OF VLA-4 AS A NEW BIOMARKER OF VASO-OCCLUSION IN SICKLE CELL DISEASE

EHA Library, Enrico Novelli, 385881

THE RELATIONSHIP BETWEEN MEDICATION ADHERENCE, BARRIERS TO MEDICATION ADHERENCE, AND QUALITY OF LIFE IN SICKLE CELL DISEASE

EHA Library, Kathryn King, 385882

OUTCOMES OF COVID-19 INFECTION IN INDIVIDUALS WITH SICKLE CELL DISEASE OR SICKLE CELL TRAIT: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Stéphanie Forté, 385883

AGEING IMPACTS HYDROXYCARBAMIDE DOSING IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Isabelle Doss, 385884

ASSESSING THE ROLE OF MICRORNAS IN HYDROXYUREA -MEDIATED HBF INDUCTION IN HAEMOGLOBINOPATHIES PATIENTS

EHA Library, Neha Kargutkar, 385885

L-GLUTAMINE: A NOVEL AND EFFECTIVE THERAPEUTIC TOOL FOR VOC REDUCTION IN SCD

EHA Library, Pablo Bartolucci, 385886

EPELEUTON, A NOVEL SYNTHETIC Ω-3 FATTY ACID, REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS UNDER PHYSIOLOGICAL FLOW CONDITIONS

EHA Library, Moayed Hamza, 385887